Aging 老化

COND-aging

11

interventions reviewed

C

top legacy tier

5

counter-evidence

C Weak 3

Disputed 🚨 High market risk

Pyrroloquinoline Quinone (PQQ)

吡咯喹啉醌 (PQQ)

Disputed 🚨 High market risk

Taiwan Regulatory Restriction 🚨 High market risk

D Counter-evidence 5

Counter-Evidence ✨ Low market risk

Nicotinamide Mononucleotide (NMN)

菸鹼醯胺單核苷酸 (NMN)

Counter-Evidence 🚨 High market risk

Nicotinamide Riboside

菸鹼醯胺核糖

Taiwan Regulatory Restriction 🚨 High market risk

Counter-Evidence 🚨 High market risk

脫氫表雄酮

Counter-Evidence 🚨 High market risk

U Insufficient 3

Calcium Alpha-Ketoglutarate

鈣阿爾法酮戊二酸

Insufficient Evidence 🚨 High market risk

Taiwan Regulatory Restriction 🚨 High market risk

AI preliminary rating · view reasons and limits